Heliox in Experimental Upper Airway Obstruction

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2007

Conditions
Airway ObstructionDyspnea
Interventions
DRUG

HELIOX

HELIOX is a mixture of Helium in Oxygen with a low density and the ability to reduce the work of breathing in subjects with airway obstruction. The fractions of Helium was altered in a different order depending on the arm of the study

Trial Locations (1)

42283

HELIOS-Klinikum / University of Witten/Herdecke, Wuppertal

All Listed Sponsors
lead

University of Witten/Herdecke

OTHER

NCT00788788 - Heliox in Experimental Upper Airway Obstruction | Biotech Hunter | Biotech Hunter